Literature DB >> 22111844

Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*.

Gail Jones1, Nilima Parry-Jones, Bridget Wilkins, Monica Else, Daniel Catovsky.   

Abstract

The British Committee for Standards in Haematology first produced guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant in 2000. This revision updates those guidelines and covers the areas of diagnosis, treatment and assessment of response to therapy.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh：

Year:  2011        PMID： 22111844     DOI： 10.1111/j.1365-2141.2011.08931.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  23 in total

Review 1.  Monoclonal B cell lymphocytosis--what does it really mean?

Authors:  Andy C Rawstron
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

Review 2.  [Hairy cell leukemia].

Authors:  S Dietrich; M Andrulis; T Zenz
Journal:  Internist (Berl)       Date:  2015-04       Impact factor: 0.743

3.  Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years.

Authors:  Fergün Yılmaz; Dilan Atilla; Nagihan Akkaş; Hale Bülbül; Nur Soyer; Derya Demir; Demet Kiper; Aylin Avcı; Filiz Vural; Güray Saydam; Fahri Şahin; Mine Hekimgil; Nazan Özsan; Raika Durusoy; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-05-13       Impact factor: 0.900

4.  Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.

Authors:  Dai Chihara; Hagop Kantarjian; Susan O'Brien; Jeffrey Jorgensen; Sherry Pierce; Stefan Faderl; Alessandra Ferrajoli; Rebecca Poku; Preetesh Jain; Phillip Thompson; Mark Brandt; Rajyalakshmi Luthra; Jan Burger; Michael Keating; Farhad Ravandi
Journal:  Br J Haematol       Date:  2016-06-15       Impact factor: 6.998

5.  Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Authors:  Michael R Grever; Omar Abdel-Wahab; Leslie A Andritsos; Versha Banerji; Jacqueline Barrientos; James S Blachly; Timothy G Call; Daniel Catovsky; Claire Dearden; Judit Demeter; Monica Else; Francesco Forconi; Alessandro Gozzetti; Anthony D Ho; James B Johnston; Jeffrey Jones; Gunnar Juliusson; Eric Kraut; Robert J Kreitman; Loree Larratt; Francesco Lauria; Gerard Lozanski; Emili Montserrat; Sameer A Parikh; Jae H Park; Aaron Polliack; Graeme R Quest; Kanti R Rai; Farhad Ravandi; Tadeusz Robak; Alan Saven; John F Seymour; Tamar Tadmor; Martin S Tallman; Constantine Tam; Enrico Tiacci; Xavier Troussard; Clive S Zent; Thorsten Zenz; Pier Luigi Zinzani; Brunangelo Falini
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

6.  Audit of compliance with the British Committee for Standards in Haematology (BCSH) revised guidelines for the diagnosis and assessment of treatment response of hairy cell leukemia in University Hospital Galway.

Authors:  K Velazquez-Kennedy; C Crowe; B Craven; J Walsh; C Prendergast; J Krawczyk
Journal:  Ir J Med Sci       Date:  2016-05-11       Impact factor: 1.568

Review 7.  Moxetumomab Pasudotox: Clinical Experience in Relapsed/Refractory Hairy Cell Leukemia.

Authors:  Julie Feurtado; Robert J Kreitman
Journal:  Clin J Oncol Nurs       Date:  2019-06-01       Impact factor: 1.027

Review 8.  Hairy Cell Leukaemia.

Authors:  Matthew Cross; Claire Dearden
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

9.  Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.

Authors:  Naval Daver; Aziz Nazha; Hagop M Kantarjian; Rodney Haltom; Farhad Ravandi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-09-14

10.  Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.

Authors:  Hidekazu Itamura; Masaru Ide; Akemi Sato; Naoko Sueoka-Aragane; Eisaburo Sueoka; Aya Nishida; Taro Masunari; Sadao Aoki; Jun Takizawa; Junji Suzumiya; Shinya Kimura
Journal:  Int J Hematol       Date:  2018-07-24       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.